Today we revisit the American Society of Clinical Oncology scientific meeting in Chicago, which concluded on Tuesday, to report on three more potentially practice-changing studies.

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By ...

"We still hold hope she will be that miracle," Odelia's mother Melissa Simonsen tells PEOPLE of her daughter's prognosis ...

Dr. Brian Collins was completing his medical residency at Georgetown University in the early 2000s when the institution ...

A multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center has found that ...

Curasight A/S ("Curasight" or "the Company") (Spotlight: CURAS) announces encouraging preliminary readout from its Phase 1 clinical trial with uTREAT® in patients with aggressive brain cancer ...

Scolyer captured the world’s attention when he volunteered for a world-first experimental treatment for brain cancer. He died ...

Researchers developed an AI tool that can classify meningiomas and predict recurrence risk using routine pathology slides, ...

A postage stamp-sized implant eliminates a dangerous waiting period that has long worsened outcomes for cancer patients.

Summary: Implanting radioactive collagen tiles during brain surgery dramatically outperforms the current standard of care for patients with newly diagnosed brain metastases. The ROADS trial reveals ...

An implanted radiation device has improved tumor control and overall survival compared with standard radiation therapy in ...

Phase 3 ROADS enrolled 204 patients across 32 centers (2021–2025) with 2–7 cm brain metastases, comparing tile-based intraoperative radiation versus external stereotactic radiation. Surgical bed ...